Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

Following global commercial launch in September, Illumina Protein Prep's "out of the box" solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed Sydney Mass Spectrometry is the first facility in the wider Asia Pacific region to offer Illumina Protein Prep, adding to a growing list of institutions revealing biological insights with exceptional [...]

OriGene Technologies and Nanoportal Biotech Join Forces to Bring Groundbreaking ProteanFect™ Gene Delivery Technology to Researchers Worldwide

Rockville, MD — OriGene Technologies, a global leader in gene-centric research tools, today announced an exclusive distributorship and a co-marketing partnership with Nanoportal Biotech for ProteanFect™, an industry-first, coacervate-based gene delivery reagent that promises to redefine transfection in challenging cell types. ProteanFect represents a major leap forward in nucleic acid delivery. Unlike conventional lipid- or polymer-based [...]

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel

Oxford, UK – Today, OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) - the SureSeq™ Myeloid MRD Plus NGS Panel. Designed using OGT’s 30 years of expertise in hybrid capture technology, the panel detects ultra-low frequency variants in key MRD-associated biomarkers in acute myeloid leukaemia (AML). This means users [...]

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

Toronto, Canada — HUPO World Congress — Evosep, a global leader in proteomics solutions, is proud to announce a new initiative at HUPO 2025 aimed at solving one of LCMS based proteomics most persistent challenges: sample preparation. Building on its legacy of standardizing proteomics LC separation, Evosep is now expanding upstream to deliver robust, and [...]

QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025

QIAsymphony Connect, the next generation of automated nucleic acid purification platform, to be shown at AMP 2025 as early access phase begins ahead of full release in mid-2026 QIAGEN showcases Sample to Insight workflows for comprehensive genomic profiling (CGP) based on Element Biosciences Trinity™ technology Partnership with Myriad Genetics Inc. to highlight development of a [...]

Abselion Launches His-tagged Protein Quantification Kit and Sensors for Amperia at PEGS Europe 2025

Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins Broadens Amperia’s applications across recombinant protein research, screening, and development Abselion to showcase kit alongside Amperia platform at PEGS Europe in Lisbon, Portugal from 11–13 November Cambridge, UK: Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has [...]

Golden Helix Launches VarSeq 3 and VSWarehouse 3

Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation BOZEMAN, Mont. -- Golden Helix, Inc. announced the release of VarSeq 3 and VSWarehouse 3, the company's next-generation platform for secondary and tertiary genomic analysis. Building on more than a decade of trusted innovation, the clinical utility of VarSeq 3 has been expanded through industry partnerships and customer collaborations. [...]

Cytiva unveils Fibro dT platform for enhanced mRNA purification

Fibro dT platform offers a high-capacity solution for mRNA purification with chromatography cycle times under 15 minutes. Sustainable performance, with recovery over 80 percent for many chromatography cycles and across different units. Helps prevent the loss of RNA molecule waste and conserves raw materials. Cytiva, a Danaher company and leader in the life sciences industry, [...]

ZEISS invests in arcoris bio to advance next-generation digital pathology technology​

Funding will accelerate commercialization of its breakthrough biomarker detection platform MUSE®. Oberkochen, Germany | ZEISS Group ZEISS Ventures participated in an oversubscribed financing round of CHF 6.3 million for arcoris bio, a Swiss start-up specializing in a platform technology aimed at enhancing biomolecule detection and imaging for spatial multiomics solutions. The funding round, co-led by [...]

Endress+Hauser expands footprint in Waldheim

The new development and production building (shown at top right) looks out over the existing production halls. The Endress+Hauser Group has opened a new development and production building for liquid analysis at its Waldheim site in Saxony, Germany. The family-owned company has had a presence in Waldheim since 1990 and has steadily grown its operations there [...]

Access IBO on Knowledge Center